Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing, and marketing products in the fields of reproductive health, urology, gastroenterology, endocrinology, and orthopedics. The company's research activities and products are connected by a common focus of providing tailored treatments that work on the body's own terms, enabling doctors to combat numerous diseases and medical conditions.
With the acquisition of the Israeli company Bio-Technology General (BTG) in 2005, Ferring gained capabilities in recombinant biotechnology as well as more traditional pharmaceutical manufacturing. There are two Ferring sites in Israel: Ferring Pharmaceuticals Israel, a manufacturing and distribution site, and Bio-Technology General, which is involved in the development of recombinant biologics and biotechnology, as well as manufacturing. Ferring and BTG actively search for in-licensing opportunities and product acquisitions in Ferring's key areas of therapeutic activity, reproductive health, endocrinology, urology, gastroenterology, and orthopedics.